This is the fourth wave.
Not sure why the other link is broken, but maybe this one works:
https://www.latimes.com/opinion/story/2 ... -therapist
This is the fourth wave.

There’s also a sub-variant of Delta that’s being watched closely and the WHO might list as variant of interest.∞∞∞ wrote: ↑Wed Sep 01, 2021 1:02 pmThis is the fourth wave.
Not sure why the other link is broken, but maybe this one works:
https://www.latimes.com/opinion/story/2 ... -therapist
I'm with BDK, I thought this was the 3rd wave....∞∞∞ wrote: ↑Wed Sep 01, 2021 1:02 pmThis is the fourth wave.
Not sure why the other link is broken, but maybe this one works:
https://www.latimes.com/opinion/story/2 ... -therapist
Well what the hell not!?

Each state looks different. Florida looks like they are on their 5th wave if you look at the charts on worldometer.Ibanez wrote: ↑Wed Sep 01, 2021 1:10 pmI'm with BDK, I thought this was the 3rd wave....∞∞∞ wrote: ↑Wed Sep 01, 2021 1:02 pm
This is the fourth wave.
Not sure why the other link is broken, but maybe this one works:
https://www.latimes.com/opinion/story/2 ... -therapist

Very true. Obviously this is nationally, but some states have had less or more waves.
At this point, the people that are really suffering and dying are those that refuse to get preventative treatment. So, I don't have much sympathy for them.

Is a ripple a wave?∞∞∞ wrote: ↑Wed Sep 01, 2021 1:02 pmThis is the fourth wave.
Not sure why the other link is broken, but maybe this one works:
https://www.latimes.com/opinion/story/2 ... -therapist
Although vaccinated people are now suffering due to the lack of hospital beds, and there's a worrying, rising trend of children getting bad Covid symptoms too.

Or never got it the first, second, third, or fourth time and developed full/partial/somewhat/tish immunity to it.

The kid thing may or may not be anything - even now, the high end estimate of kids getting a severe case of COVID is like 1% of all infections among kids, and that's the high end. That's pretty small. But, still all the more reason for the government to get the vaccine approved for the under-12 set. That's been a failing of this response to COVID. We've had the vaccine for about 10 months now, and we're still several months away, at best, from having the recommended dosage amount for the under-12 set. That continues to be a missed aspect of this.
I don't know the specifics, but from what I've read it's a lack of data. The first vaccine was developed quickly because there was an overwhelming amount of volunteers. Getting data on younger people is tougher, especially under-12 as we need caretakers to basically volunteer children for clinical trials. And it needs to have enough variety with regards to age, sex, race, etc.GannonFan wrote: ↑Wed Sep 01, 2021 1:39 pmThe kid thing may or may not be anything - even now, the high end estimate of kids getting a severe case of COVID is like 1% of all infections among kids, and that's the high end. That's pretty small. But, still all the more reason for the government to get the vaccine approved for the under-12 set. That's been a failing of this response to COVID. We've had the vaccine for about 10 months now, and we're still several months away, at best, from having the recommended dosage amount for the under-12 set. That continues to be a missed aspect of this.

OK, I now know 3 people with bad cases since the start. Buddy in the hospital since Monday, not sure if he was vaxed or not. He seems to be improving.89Hen wrote: ↑Mon Aug 30, 2021 2:31 pm I think I must be the luckiest person in the US. I still don't know anyone first hand who died or who went to the hospital with Covid. I know only one couple (husband and wife) who had bad symptoms, and that was March 2020. Gil on the other hand has lost half his family and friends to it.


Still at zero here. As far as I know there has not been one hospitalization at the two work locations I usually work out of. And that includes probably about 500 people.89Hen wrote: ↑Wed Sep 01, 2021 2:16 pmOK, I now know 3 people with bad cases since the start. Buddy in the hospital since Monday, not sure if he was vaxed or not. He seems to be improving.89Hen wrote: ↑Mon Aug 30, 2021 2:31 pm I think I must be the luckiest person in the US. I still don't know anyone first hand who died or who went to the hospital with Covid. I know only one couple (husband and wife) who had bad symptoms, and that was March 2020. Gil on the other hand has lost half his family and friends to it.

Mukalm wrote: ↑Wed Sep 01, 2021 1:04 pmThere’s also a sub-variant of Delta that’s being watched closely and the WHO might list as variant of interest.∞∞∞ wrote: ↑Wed Sep 01, 2021 1:02 pm
This is the fourth wave.
Not sure why the other link is broken, but maybe this one works:
https://www.latimes.com/opinion/story/2 ... -therapist

He recovered pretty quickly, although I have questions as to where he got his medications. Monoclonal antibodies, ivermectin, NAD drip, etc.

Well whatever he took seems to have worked. Not sure what trip would like to discuss about it.SeattleGriz wrote: ↑Wed Sep 01, 2021 5:47 pmHe recovered pretty quickly, although I have questions as to where he got his medications. Monoclonal antibodies, ivermectin, NAD drip, etc.
I have a coworker who just caught COVID along with her husband and daughter. Got ivermectin prescribed and she has said it was no worse than a regular cold. In fact, she was working yesterday and today.
My point in all this, is there's quite a bit of difference between what she took and what Rogan took.


How long ago did he have it?SeattleGriz wrote: ↑Wed Sep 01, 2021 5:47 pmHe recovered pretty quickly, although I have questions as to where he got his medications. Monoclonal antibodies, ivermectin, NAD drip, etc.
I have a coworker who just caught COVID along with her husband and daughter. Got ivermectin prescribed and she has said it was no worse than a regular cold. In fact, she was working yesterday and today.
My point in all this, is there's quite a bit of difference between what she took and what Rogan took.

Sounds like about 4-5 days? As far as his stance, he stated that he wasn't a doctor, but a moron. Also still feels there are those that don't need to get the vaccine.kalm wrote: ↑Wed Sep 01, 2021 6:38 pmHow long ago did he have it?SeattleGriz wrote: ↑Wed Sep 01, 2021 5:47 pm
He recovered pretty quickly, although I have questions as to where he got his medications. Monoclonal antibodies, ivermectin, NAD drip, etc.
I have a coworker who just caught COVID along with her husband and daughter. Got ivermectin prescribed and she has said it was no worse than a regular cold. In fact, she was working yesterday and today.
My point in all this, is there's quite a bit of difference between what she took and what Rogan took.
Has he changed his tune at all?
Didn't he have a doctor on a few days ago telling him he's wrong? Yet continued to spread misinformation, gets COVID, receives at least one expensive treatment others rarely get, then goes "SEE THIS WORKS!" Plus I don't know about you, but this is a really tough decision:SeattleGriz wrote: ↑Wed Sep 01, 2021 7:29 pmSounds like about 4-5 days? As far as his stance, he stated that he wasn't a doctor, but a moron. Also still feels there are those that don't need to get the vaccine.

A large, randomized trial led by researchers at Stanford Medicine and Yale University has found that wearing a surgical face mask over the mouth and nose is an effective way to reduce the occurrence of COVID-19 in community settings.
It also showed that relatively low-cost, targeted interventions to promote mask-wearing can significantly increase the use of face coverings in rural, low-income countries. Based on the results, the interventional model is being scaled up to reach tens of millions of people in Southeast Asia and Latin America over the next few months.
The findings were released Sept. 1 on the Innovations for Poverty Action website, prior to their publication in a scientific journal, because the information is considered of pressing importance for public health as the pandemic worsens in many parts of the world.
“We now have evidence from a randomized, controlled trial that mask promotion increases the use of face coverings and prevents the spread of COVID-19,” said Stephen Luby, MD, professor of medicine at Stanford. “This is the gold standard for evaluating public health interventions. Importantly, this approach was designed be scalable in lower- and middle-income countries struggling to get or distribute vaccines against the virus.”
Luby shares senior authorship with Ahmed Mushfiq Mobarak, PhD, professor of economics at Yale, of a paper describing the research. The lead authors are Ashley Styczynski, MD, MPH, an infectious disease fellow at Stanford; Jason Abaluck, PhD, professor of economics at Yale; and Laura Kwong, PhD, a former postdoctoral scholar at Stanford who is now an assistant professor of environmental health sciences at the University of California-Berkeley.

kalm wrote: ↑Thu Sep 02, 2021 5:00 am Shocker!
A large, randomized trial led by researchers at Stanford Medicine and Yale University has found that wearing a surgical face mask over the mouth and nose is an effective way to reduce the occurrence of COVID-19 in community settings.
It also showed that relatively low-cost, targeted interventions to promote mask-wearing can significantly increase the use of face coverings in rural, low-income countries. Based on the results, the interventional model is being scaled up to reach tens of millions of people in Southeast Asia and Latin America over the next few months.
The findings were released Sept. 1 on the Innovations for Poverty Action website, prior to their publication in a scientific journal, because the information is considered of pressing importance for public health as the pandemic worsens in many parts of the world.
“We now have evidence from a randomized, controlled trial that mask promotion increases the use of face coverings and prevents the spread of COVID-19,” said Stephen Luby, MD, professor of medicine at Stanford. “This is the gold standard for evaluating public health interventions. Importantly, this approach was designed be scalable in lower- and middle-income countries struggling to get or distribute vaccines against the virus.”
Luby shares senior authorship with Ahmed Mushfiq Mobarak, PhD, professor of economics at Yale, of a paper describing the research. The lead authors are Ashley Styczynski, MD, MPH, an infectious disease fellow at Stanford; Jason Abaluck, PhD, professor of economics at Yale; and Laura Kwong, PhD, a former postdoctoral scholar at Stanford who is now an assistant professor of environmental health sciences at the University of California-Berkeley.
https://med.stanford.edu/news/all-news/ ... uXqu-VRD70